Patient Recruitment Featured Articles

  1. Bridging Language And Medicine: Best Practices In French Regulatory Medical Writing 3/27/2026

    Poor translations are not just clunky. They can be risky. Medical-linguistic consultant Farah Ayadi, PharmD, explains its implications for safety, regulatory submissions, and downstream operational or financial outcomes.

  2. The Art Of Finding And Keeping The Right KOL 3/18/2026

    Learn from Incyclix CEO Patrick Roberts how the company identifies its KOLs, tailors engagement to their expertise, measures collaboration success, and sustains successful long-term partnerships.

  3. Wanted: More Women For Clinical Trials 3/13/2026

    A new national survey from UPMC’s Center for Connected Medicine examines why women remain underrepresented in clinical trials. The research highlights key barriers such as fear of side effects, time and travel burdens, and limited awareness about how trials work. In a conversation with UPMC’s Nicole Ansani, we explore what sites and sponsors can do to make trials more accessible and appealing to women.

  4. PolarityBio Loosens I/E And Taps Many Provider Types To Reach More Patients 3/13/2026

    Discover how PolarityBio widened enrollment criteria and even developed improved delivery model to better serve investigators and patients in its Phase 3 trial for diabetic foot ulcers.

  5. How The ACA Subsidy Lapse Could Hurt Clinical Trial Enrollment 3/12/2026

    The relationship between the Affordable Care Act (ACA) enhanced premium subsidies and clinical research isn’t widely understood, so consultant Devra Densmore is clearing things up, including how coverage loss could impact trial enrollment.

  6. Why Africa Could Be The Next Frontier For Clinical Trials 3/6/2026

    Africa hosts only about 3% of global clinical trials despite representing roughly 20% of the world’s population. Tariro Makadzange, founder and CEO of the Africa Clinical Research Network (ACRN), explains how the organization aims to build a continent-wide clinical trial platform and increase that share to 15% over the next decade.

  7. How Keenova Reignited A Stalled Trial 3/3/2026

    When a difficult-to-enroll Phase 3 study stalled, Keenova found momentum not through new technology but through relationships, collaboration, and fair site support. By listening to site feedback, rethinking communication, empowering peer learning, and revisiting compensation, the team transformed engagement and enrollment. 

  8. When A Clinical Trial Surfaces In An AI Chat, What Happens Next? 3/2/2026

    AI is soon becoming the first interpreter of your clinical trial. Understand its implications for enrollment design, screening efficiency, and ultimately program predictability.

  9. AI Trial Matching Comes Of Age At City Of Hope 2/19/2026

    City of Hope has embedded an internally trained AI platform into oncology care and research workflows, helping clinicians summarize complex patient histories and match patients to clinical trials in real time. By reducing manual review and accelerating feasibility assessments across its national network, the system is improving trial access, easing clinician workload, and shifting more time back to patient care.

  10. The Problem With Excluding Children From GLP-1 Trials In The U.S. 2/19/2026

    In the U.S., roughly 15 million children are obese. But many are excluded from GLP-1 research. Obesity expert Evan Nadler, MD, explains why that's problematic.